Impact of TP53 Mutations on EGFR-Tyrosine Kinase Inhibitor Efficacy and Potential Treatment Strategy
Jing Fu, Yuyang Tong, Ziguang Xu, Yaonan Li, Zhao Ya, Tao Wang, Cuidan Li, Shundong Cang
Topics & Concepts
MedicineOncologyInternal medicineExact testChemotherapyTyrosine-kinase inhibitorTyrosine kinaseLog-rank testAcquired resistanceOsimertinibMutationSurvival analysisEpidermal growth factor receptorCancerGeneErlotinibReceptorGeneticsBiologyLung Cancer Treatments and MutationsChronic Lymphocytic Leukemia ResearchCancer Genomics and Diagnostics